CYD CYD
Company Profile ↓Company Overview
CYD (CYD) is a publicly traded company listed on with a market capitalization of $2.00B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 35.0% per year over the last five years.
Revenue has grown at a 15.4% CAGR over the past five years.
Trades at an undemanding P/E of 3.4.
Carries low leverage with a debt-to-equity ratio of 0.22.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $24.66B (+28.9% YoY); net profit $537.39M.
- Trailing 12 Months Year-on-year growth — revenue +28.9%, earnings +66.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 15.4%, profit CAGR 35.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 15.44% |
| 1 Year: | 28.89% |
Compounded Profit Growth
| 5 Years: | 34.97% |
| 1 Year: | 66.35% |
Stock Price Performance
| 1 Year: | +111.22% |
| 6 Months: | +3.16% |
| 3 Months: | +24.23% |
| 1 Month: | +6.63% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.84 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 15.4% over 5 years.
- Profit CAGR of 35.0% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 16.03B | 18.05B | 19.13B | 24.66B |
| Cost of Revenue | - | 13.86B | 15.50B | 16.32B | 20.59B |
| Gross Profit | - | 2.17B | 2.54B | 2.82B | 4.07B |
| Operating Expenses | - | 1.80B | 2.17B | 2.35B | 3.09B |
| Operating Income | - | 374.86M | 371.07M | 469.47M | 978.99M |
| EBITDA | - | 1.11B | 1.33B | 1.41B | 1.91B |
| Interest Expense | - | 90.91M | 95.59M | 74.04M | 55.75M |
| Pretax Income | - | 394.73M | 571.35M | 620.54M | 1.14B |
| Tax Provision | - | 59.06M | 148.50M | 128.80M | 329.68M |
| Net Income | - | 218.58M | 285.52M | 323.06M | 537.39M |
| Diluted EPS | - | 5.35 | 6.99 | 8.21 | 14.32 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 24.14B | 25.76B | 27.05B | 31.96B |
| Current Assets | - | 17.10B | 19.16B | 20.52B | 25.16B |
| Cash & Equivalents | - | 4.80B | 6.01B | 6.31B | 7.85B |
| Inventory | - | 4.95B | 4.67B | 4.67B | 5.58B |
| Receivables | - | 1.82B | 1.49B | 1.60B | 2.46B |
| Total Liabilities | - | 12.30B | 13.58B | 14.75B | 19.06B |
| Current Liabilities | - | 11.22B | 12.06B | 13.23B | 18.08B |
| Long Term Debt | - | 200.00M | 690.00M | 638.00M | 20.00M |
| Total Debt | - | 2.40B | 2.59B | 2.57B | 2.10B |
| Total Equity | - | 9.01B | 9.23B | 9.16B | 9.58B |
| Shares Outstanding | - | 40.86M | 40.86M | 40.86M | 40.86M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -119.42M | 1.23B | 779.42M | 2.72B |
| Investing Cash Flow | - | -133.05M | -113.26M | 113.10M | -274.36M |
| Financing Cash Flow | - | -140.37M | -33.74M | -526.63M | -828.03M |
| Capital Expenditure | - | -597.25M | -407.43M | -545.24M | -651.34M |
| Free Cash Flow | - | -716.67M | 818.61M | 234.18M | 2.07B |
| Net Change in Cash | - | -392.83M | 1.08B | 365.88M | 1.62B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 13.6% | 14.1% | 14.7% | 16.5% |
| Operating Margin % | - | 2.3% | 2.1% | 2.5% | 4.0% |
| Net Margin % | - | 1.4% | 1.6% | 1.7% | 2.2% |
| ROE % | - | 2.4% | 3.1% | 3.5% | 5.6% |
| ROCE % | - | 2.9% | 2.7% | 3.4% | 7.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CYD
CYD vs. HSAI: Which Stock Should Value Investors Buy Now? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOZnJMaHRTUHJ0cW01ZlluNmFuVDd1NEJGUWtHMGNUMGVzWFUtVlU3RnQteUxmdG41U2NjV2dFVW9wQ01GZDFsVUNNMFl3WWdNb0VBWEo3RWJXY3BrSHc4QnQxTHZMNWdtd1pTWVdubXZKNW9jMFlFNHFNWFhVV3pzQTRMVFJINmRsNnNLRz…
How Investors Are Reacting To China Yuchai International (CYD) Earnings Upgrade Amid Rising R&D Costs - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxQbkxuQnk2ZWNHY1g2c2pKYk1sQ2owU2NmaHIwVUZGX0hnNWZmV1dIakhmT1ltYmRldkNxako3cE9IQVhINGZWZEVQZDlkdjVtMFZqYUg0bVFsZnNtQ052ck1YMkNCcEpoZjFabTUtQ3hrM2FtbVNIUXFGQU8tcWhPQXRDTGdCTzNxZ216Tj…
Wall Street Analysts See a 39.34% Upside in China Yuchai (CYD): Can the Stock Really Move This High? - Zacks Investment Research
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNekd2a0pMc2xNRVdjajJab3hSRkFWZTJBWjRSdkJITDk5NC1TZy1BM1UyZmk4ek5xRFRSSDBaQWhhYXlOdUpHRGVGbnRxLXF2UHNCc2hzYXoyVTg2azkzeEJqSWN3SHMwUmRjNUVfNzYwSElDV0QtaWJEQkZRRFdteGpFVWZUdmRzaFg2WE…
Renaissance Technologies LLC Raises Stake in China Yuchai International Limited $CYD - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxPZmtIN1R0RnJnMkc1Yl9JNjdRTEdScDl4dElhTUY0MTdfemY4ZlJwREVQUE1lVkZuWWN1blU4LUQwcDQ3Mzc0SldJRWllS0NvazIwdnVmM3RIS2xEVjJDM0JOMHR4bThUa3B1d2tydDhKRVVnVkZ4d3FRNUlDamZKVzJnSGpMc0ZUU1Q0WT…
China Yuchai International Ltd (CYD) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVE1HTGlpREVld1UtZDFXZU1kNm5NY1pZZzlsMG01WnRackZYdXRiR21rb3hWU0xReDBTSDVRWGdrY01oTGJJbldGNXRBUEU4T21tWVZsQlVRajRvWGdkR3RHUUhFN05pOEloVkhPTEszb2NBb2YxTVhNck0xNlNFM1dEYi1UVFBaUVdCbG…
China Yuchai International (NYSE: CYD) sets Aug. 7 call on H1 2026 results - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQX1RJeUdRWVJEOUZUMGNOUXlUbFptRHBLeXJnLVF2UXJaRWx2VlUtSWlZNTBBdjZvVUN2TExtVGdKUXc2TWE5NFBWbzhpUXRuU3czVlBWaV9ZNTZDdi1PMUF6ektpWWpMbUhRcUkxNkZXTm42Z3c0WnJGM3JzNFd6eFhOS1VZR3pJejY2TW…
CYD — Frequently Asked Questions
What is the current share price of CYD?
As of 2026-08-05 17:25 PDT, CYD trades at $48.92 on NASDAQ/NYSE. Its 52-week range is $23.16 to $58.55.
What is the market capitalisation of CYD?
CYD has a market capitalisation of $2.00B on NASDAQ/NYSE.
What is the P/E ratio of CYD?
CYD trades at a trailing price-to-earnings (P/E) ratio of 3.42. Its price-to-book (P/B) ratio is 0.21.
What is the return on equity (ROE) of CYD?
CYD has a return on equity (ROE) of 5.61%. Its return on capital employed (ROCE) is 7.05%.
Is CYD a good stock to buy?
This page provides a data-driven analysis of CYD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.